Flagship co-founded Codon Devices in the fall of 2004 with leading academics George Church (Harvard Medical School), Joe Jacobson (MIT), Drew Endy (MIT), and Jay Keasling (UC Berkeley). The company is currently developing its proprietary BioFABTM production platform that is expected to accurately synthesize kilobase- to megabase-length genetic code, orders of magnitude more rapidly and less expensively than currently available technology. In the short term, product opportunities include comprehensive sets of biological parts for large-scale research projects, engineered cells that produce novel pharmaceuticals, engineered protein biotherapeutics and novel biosensor devices. In the longer term, the company’s core technology is expected to enable improved vaccines, agricultural products and biorefineries for the production of industrial chemicals and energy. With initial leadership from Flagship, Codon created a strong IP portfolio, recruited world-class Scientific Advisors, and secured contracts for revenues in its first year. Flagship Managing Partner Noubar Afeyan is Chairman of the Board.

www.codondevices.com